Cargando…

Virtual Patient-Specific Quality Assurance of IMRT Using UNet++: Classification, Gamma Passing Rates Prediction, and Dose Difference Prediction

The dose verification in radiotherapy quality assurance (QA) is time-consuming and places a heavy workload on medical physicists. To provide a clinical tool to perform patient specific QA accurately, the UNet++ is investigated to classify failed or pass fields (the GPR lower than 85% is considered “...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Ying, Pi, Yifei, Ma, Kui, Miao, Xiaojuan, Fu, Sichao, Chen, Hua, Wang, Hao, Gu, Hengle, Shao, Yan, Duan, Yanhua, Feng, Aihui, Wang, Jiyong, Cai, Ruxin, Zhuo, Weihai, Xu, Zhiyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330420/
https://www.ncbi.nlm.nih.gov/pubmed/34354949
http://dx.doi.org/10.3389/fonc.2021.700343
_version_ 1783732712517926912
author Huang, Ying
Pi, Yifei
Ma, Kui
Miao, Xiaojuan
Fu, Sichao
Chen, Hua
Wang, Hao
Gu, Hengle
Shao, Yan
Duan, Yanhua
Feng, Aihui
Wang, Jiyong
Cai, Ruxin
Zhuo, Weihai
Xu, Zhiyong
author_facet Huang, Ying
Pi, Yifei
Ma, Kui
Miao, Xiaojuan
Fu, Sichao
Chen, Hua
Wang, Hao
Gu, Hengle
Shao, Yan
Duan, Yanhua
Feng, Aihui
Wang, Jiyong
Cai, Ruxin
Zhuo, Weihai
Xu, Zhiyong
author_sort Huang, Ying
collection PubMed
description The dose verification in radiotherapy quality assurance (QA) is time-consuming and places a heavy workload on medical physicists. To provide a clinical tool to perform patient specific QA accurately, the UNet++ is investigated to classify failed or pass fields (the GPR lower than 85% is considered “failed” while the GPR higher than 85% is considered “pass”), predict gamma passing rates (GPR) for different gamma criteria, and predict dose difference from virtual patient-specific quality assurance in radiotherapy. UNet++ was trained and validated with 473 fields and tested with 95 fields. All plans used Portal Dosimetry for dose verification pre-treatment. Planar dose distribution of each field was used as the input for UNet++, with QA classification results, gamma passing rates of different gamma criteria, and dose difference were used as the output. In the test set, the accuracy of the classification model was 95.79%. The mean absolute error (MAE) were 0.82, 0.88, 2.11, 2.52, and the root mean squared error (RMSE) were 1.38, 1.57, 3.33, 3.72 for 3%/3mm, 3%/2 mm, 2%/3 mm, 2%/2 mm, respectively. The trend and position of the predicted dose difference were consistent with the measured dose difference. In conclusion, the Virtual QA based on UNet++ can be used to classify the field passed or not, predict gamma pass rate for different gamma criteria, and predict dose difference. The results show that UNet++ based Virtual QA is promising in quality assurance for radiotherapy.
format Online
Article
Text
id pubmed-8330420
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-83304202021-08-04 Virtual Patient-Specific Quality Assurance of IMRT Using UNet++: Classification, Gamma Passing Rates Prediction, and Dose Difference Prediction Huang, Ying Pi, Yifei Ma, Kui Miao, Xiaojuan Fu, Sichao Chen, Hua Wang, Hao Gu, Hengle Shao, Yan Duan, Yanhua Feng, Aihui Wang, Jiyong Cai, Ruxin Zhuo, Weihai Xu, Zhiyong Front Oncol Oncology The dose verification in radiotherapy quality assurance (QA) is time-consuming and places a heavy workload on medical physicists. To provide a clinical tool to perform patient specific QA accurately, the UNet++ is investigated to classify failed or pass fields (the GPR lower than 85% is considered “failed” while the GPR higher than 85% is considered “pass”), predict gamma passing rates (GPR) for different gamma criteria, and predict dose difference from virtual patient-specific quality assurance in radiotherapy. UNet++ was trained and validated with 473 fields and tested with 95 fields. All plans used Portal Dosimetry for dose verification pre-treatment. Planar dose distribution of each field was used as the input for UNet++, with QA classification results, gamma passing rates of different gamma criteria, and dose difference were used as the output. In the test set, the accuracy of the classification model was 95.79%. The mean absolute error (MAE) were 0.82, 0.88, 2.11, 2.52, and the root mean squared error (RMSE) were 1.38, 1.57, 3.33, 3.72 for 3%/3mm, 3%/2 mm, 2%/3 mm, 2%/2 mm, respectively. The trend and position of the predicted dose difference were consistent with the measured dose difference. In conclusion, the Virtual QA based on UNet++ can be used to classify the field passed or not, predict gamma pass rate for different gamma criteria, and predict dose difference. The results show that UNet++ based Virtual QA is promising in quality assurance for radiotherapy. Frontiers Media S.A. 2021-07-20 /pmc/articles/PMC8330420/ /pubmed/34354949 http://dx.doi.org/10.3389/fonc.2021.700343 Text en Copyright © 2021 Huang, Pi, Ma, Miao, Fu, Chen, Wang, Gu, Shao, Duan, Feng, Wang, Cai, Zhuo and Xu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Huang, Ying
Pi, Yifei
Ma, Kui
Miao, Xiaojuan
Fu, Sichao
Chen, Hua
Wang, Hao
Gu, Hengle
Shao, Yan
Duan, Yanhua
Feng, Aihui
Wang, Jiyong
Cai, Ruxin
Zhuo, Weihai
Xu, Zhiyong
Virtual Patient-Specific Quality Assurance of IMRT Using UNet++: Classification, Gamma Passing Rates Prediction, and Dose Difference Prediction
title Virtual Patient-Specific Quality Assurance of IMRT Using UNet++: Classification, Gamma Passing Rates Prediction, and Dose Difference Prediction
title_full Virtual Patient-Specific Quality Assurance of IMRT Using UNet++: Classification, Gamma Passing Rates Prediction, and Dose Difference Prediction
title_fullStr Virtual Patient-Specific Quality Assurance of IMRT Using UNet++: Classification, Gamma Passing Rates Prediction, and Dose Difference Prediction
title_full_unstemmed Virtual Patient-Specific Quality Assurance of IMRT Using UNet++: Classification, Gamma Passing Rates Prediction, and Dose Difference Prediction
title_short Virtual Patient-Specific Quality Assurance of IMRT Using UNet++: Classification, Gamma Passing Rates Prediction, and Dose Difference Prediction
title_sort virtual patient-specific quality assurance of imrt using unet++: classification, gamma passing rates prediction, and dose difference prediction
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330420/
https://www.ncbi.nlm.nih.gov/pubmed/34354949
http://dx.doi.org/10.3389/fonc.2021.700343
work_keys_str_mv AT huangying virtualpatientspecificqualityassuranceofimrtusingunetclassificationgammapassingratespredictionanddosedifferenceprediction
AT piyifei virtualpatientspecificqualityassuranceofimrtusingunetclassificationgammapassingratespredictionanddosedifferenceprediction
AT makui virtualpatientspecificqualityassuranceofimrtusingunetclassificationgammapassingratespredictionanddosedifferenceprediction
AT miaoxiaojuan virtualpatientspecificqualityassuranceofimrtusingunetclassificationgammapassingratespredictionanddosedifferenceprediction
AT fusichao virtualpatientspecificqualityassuranceofimrtusingunetclassificationgammapassingratespredictionanddosedifferenceprediction
AT chenhua virtualpatientspecificqualityassuranceofimrtusingunetclassificationgammapassingratespredictionanddosedifferenceprediction
AT wanghao virtualpatientspecificqualityassuranceofimrtusingunetclassificationgammapassingratespredictionanddosedifferenceprediction
AT guhengle virtualpatientspecificqualityassuranceofimrtusingunetclassificationgammapassingratespredictionanddosedifferenceprediction
AT shaoyan virtualpatientspecificqualityassuranceofimrtusingunetclassificationgammapassingratespredictionanddosedifferenceprediction
AT duanyanhua virtualpatientspecificqualityassuranceofimrtusingunetclassificationgammapassingratespredictionanddosedifferenceprediction
AT fengaihui virtualpatientspecificqualityassuranceofimrtusingunetclassificationgammapassingratespredictionanddosedifferenceprediction
AT wangjiyong virtualpatientspecificqualityassuranceofimrtusingunetclassificationgammapassingratespredictionanddosedifferenceprediction
AT cairuxin virtualpatientspecificqualityassuranceofimrtusingunetclassificationgammapassingratespredictionanddosedifferenceprediction
AT zhuoweihai virtualpatientspecificqualityassuranceofimrtusingunetclassificationgammapassingratespredictionanddosedifferenceprediction
AT xuzhiyong virtualpatientspecificqualityassuranceofimrtusingunetclassificationgammapassingratespredictionanddosedifferenceprediction